391 related articles for article (PubMed ID: 27522516)
1. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Rageth CJ; O'Flynn EA; Comstock C; Kurtz C; Kubik R; Madjar H; Lepori D; Kampmann G; Mundinger A; Baege A; Decker T; Hosch S; Tausch C; Delaloye JF; Morris E; Varga Z
Breast Cancer Res Treat; 2016 Sep; 159(2):203-13. PubMed ID: 27522516
[TBL] [Abstract][Full Text] [Related]
2. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Rageth CJ; O'Flynn EAM; Pinker K; Kubik-Huch RA; Mundinger A; Decker T; Tausch C; Dammann F; Baltzer PA; Fallenberg EM; Foschini MP; Dellas S; Knauer M; Malhaire C; Sonnenschein M; Boos A; Morris E; Varga Z
Breast Cancer Res Treat; 2019 Apr; 174(2):279-296. PubMed ID: 30506111
[TBL] [Abstract][Full Text] [Related]
3. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C; Leo C; Kubik-Huch RA; Muenst S; Schmidt N; Quinn C; McNally S; van Diest PJ; Mann RM; Bago-Horvath Z; Bernathova M; Regitnig P; Fuchsjäger M; Schwegler-Guggemos D; Maranta M; Zehbe S; Tausch C; Güth U; Fallenberg EM; Schrading S; Kothari A; Sonnenschein M; Kampmann G; Kulka J; Tille JC; Körner M; Decker T; Lax SF; Daniaux M; Bjelic-Radisic V; Kacerovsky-Strobl S; Condorelli R; Gnant M; Varga Z
Virchows Arch; 2023 Jul; 483(1):5-20. PubMed ID: 37330436
[TBL] [Abstract][Full Text] [Related]
4. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
Willers N; Neven P; Floris G; Colpaert C; Oldenburger E; Han S; Van Ongeval C; Smeets A; Duhoux FP; Wildiers H; Denolf P; Laudus N; Dequeker E; De Brabander I; Van Damme N; De Schutter H
Clin Breast Cancer; 2023 Jun; 23(4):e273-e280. PubMed ID: 37085379
[TBL] [Abstract][Full Text] [Related]
5. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
Lucioni M; Rossi C; Lomoro P; Ballati F; Fanizza M; Ferrari A; Garcia-Etienne CA; Boveri E; Meloni G; Sommaruga MG; Ferraris E; Lasagna A; Bonzano E; Paulli M; Sgarella A; Di Giulio G
Eur Radiol; 2021 Feb; 31(2):920-927. PubMed ID: 32816199
[TBL] [Abstract][Full Text] [Related]
6. The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis.
Cullinane C; Byrne J; Kelly L; O Sullivan M; Antony Corrigan M; Paul Redmond H
Eur J Surg Oncol; 2022 Jul; 48(7):1464-1474. PubMed ID: 35491362
[TBL] [Abstract][Full Text] [Related]
7. Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result.
Santucci D; Faiella E; Calabrese A; Favale L; Zobel BB; de Felice C
Clin Breast Cancer; 2019 Oct; 19(5):e643-e653. PubMed ID: 31377083
[TBL] [Abstract][Full Text] [Related]
8. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
[TBL] [Abstract][Full Text] [Related]
9. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
10. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
Okamoto S; Chen ST; Covelli JD; DeMartini WB; Daniel BL; Ikeda DM
Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725
[TBL] [Abstract][Full Text] [Related]
11. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
[TBL] [Abstract][Full Text] [Related]
12. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
[TBL] [Abstract][Full Text] [Related]
13. Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?
Preibsch H; Wanner LK; Staebler A; Hahn M; Siegmann-Luz KC
BMC Med Imaging; 2018 Sep; 18(1):27. PubMed ID: 30200900
[TBL] [Abstract][Full Text] [Related]
14. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
Rubio IT; Wyld L; Marotti L; Athanasiou A; Regitnig P; Catanuto G; Schoones JW; Zambon M; Camps J; Santini D; Dietz J; Sardanelli F; Varga Z; Smidt M; Sharma N; Shaaban AM; Gilbert F
Eur J Surg Oncol; 2024 Jan; 50(1):107292. PubMed ID: 38061151
[TBL] [Abstract][Full Text] [Related]
15. The management of lobular neoplasia identified on percutaneous core breast biopsy.
Bauer VP; Ditkoff BA; Schnabel F; Brenin D; El-Tamer M; Smith S
Breast J; 2003; 9(1):4-9. PubMed ID: 12558663
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of high-risk breast lesions diagnosed using image-guided core needle biopsy: results from a multicenter retrospective study.
Oktay A; Aslan Ö; Taşkın F; Tunçbilek N; Esen İçten SG; Balcı P; Arıbal ME; Çelik L; Örgüç İŞ; Başaran Demirkazık F; Gültekin S; Aydın AM; Durmaz E; Kul S; Binokay F; Çetin M; Emlik GD; Akpınar MG; Kadıoğlu Voyvoda SN; Polat AV; Başara Akın I; Yıldız Ş; Poyraz N; Özsoy A; Öztekin PS; Elverici E; Bayrak İK; İkizceli T; Dinç F; Sezgin G; Gülşen G; Tunçbilek I; Yalçın SR; Çolakoğlu G; Ağlamış S; Yılmaz R; Rona G; Durhan G; Güner DC; Çelik Yabul F; Günbey Karabekmez L; Tutar B; Göktaş M; Buğdaycı O; Suner A; Özdemirhttps/Orcid Org/ N
Diagn Interv Radiol; 2023 Jul; 29(4):579-587. PubMed ID: 36994925
[TBL] [Abstract][Full Text] [Related]
17. Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy.
Mayer S; Kayser G; Rücker G; Bögner D; Hirschfeld M; Hug C; Stickeler E; Gitsch G; Erbes T
Breast; 2017 Feb; 31():144-149. PubMed ID: 27866089
[TBL] [Abstract][Full Text] [Related]
18. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
[TBL] [Abstract][Full Text] [Related]
19. B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019).
Huang YY; Park H; McLaren S; Thirunavukkarasu P; Lin JTW; Rajakaruna R; Dhillon R; Ponniah AK
ANZ J Surg; 2020 Dec; 90(12):2521-2526. PubMed ID: 32969161
[TBL] [Abstract][Full Text] [Related]
20. Flat epithelial atypia: are we being too aggressive?
DiPasquale A; Silverman S; Farag E; Peiris L
Breast Cancer Res Treat; 2020 Jan; 179(2):511-517. PubMed ID: 31701300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
